Quanterix Corporation

NASDAQ:QTRX

Medical - Devices

Healthcare
$2.07 +15.80%

+$0.46 today

Market cap
$98.28M
Beta
1.12
P/E (TTM)
-1.5
EPS (TTM)
-$2.22
52W Low $2.40High $8.77

Volume 3.54M

Average 1.15M

QTRX Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Quanterix CorporationNASDAQ: QTRX

Operating Margin · Q1 FY2026 · quarter ended Mar 2026

Operating margin widens to -59.1%

Operating margin was -59.1% in Q1 FY2026, up 28.0 pp from a year earlier. On a trailing-twelve-month basis it was -82.7%, down 35.0 pp year over year. Over 3 fiscal years it widened by 19.6 pp.

Context

  • Operating margin widened in 1 of the last 3 fiscal years.

What to watch

Whether operating margin reaches the consensus estimate from 2 analysts of -67.7% for the fiscal year ending Dec 2026, up from -79.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-59.1%-4.7 pp QoQ
Last fiscal yearDec 2025
-79.2%-40.4 pp YoY
LTMMar 2026
-82.7%-35.0 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+28.0 pp+99.8 pp+71.9 pp
1 year-40.4 pp+11.5 pp+51.8 pp
3 years+19.6 pp+53.6 pp+34.0 pp
5 years+67.4 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-79.2%
Year-over-year change
-40.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How QTRX compares with its peers on the latest reported figures

  • QTRX's LTM Mar 2026 operating margin of -82.7% is the 7th highest of the 10 companies compared; the peer median is -52.5%.
  • Its year-over-year change of -35.0 pp is the lowest of 10, against a peer median of +18.8 pp.
  • Over three fiscal years its change of +19.6 pp compares with a peer median of +69.7 pp.
QTRX Competitors Peer median
Operating Margin for QTRX and competitors
Company Period LTM level YoY 3-year change
VMDViemed Healthcare, Inc.LTM Mar 20268.4% -0.0 pp+1.7 pp
SNWVSANUWAVE Health, Inc.LTM Mar 20266.4% -14.2 pp+64.7 pp
INGNInogen, Inc.LTM Mar 2026-8.8% +1.2 pp+13.9 pp
SGHTSight Sciences, Inc.LTM Mar 2026-44.8% +18.8 pp+69.7 pp
MASS908 Devices Inc.LTM Mar 2026-52.5% +61.2 pp+32.5 pp
OMOutset Medical, Inc.LTM Mar 2026-56.9% +23.6 pp+83.7 pp
QTRXQuanterix CorporationLTM Mar 2026-82.7% -35.0 pp+19.6 pp
CVRXCVRx, Inc.LTM Mar 2026-84.6% +11.3 pp+98.8 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-213.0% +83.0 pp+224.9 pp
NNOXNano-X Imaging Ltd.LTM Dec 2025-466.2% +36.4 pp+812.8 pp
IMRXImmuneering CorporationFY2025— ——
Peer median (excluding QTRX) -52.5%+18.8 pp+69.7 pp

Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue110.56M105.52M121.14M135.44M138.65M
Cost of Revenue45.78M60.16M48.14M54.32M73.94M
Gross Profit64.77M45.36M73M81.12M64.72M
Gross Margin58.6%43.0%60.3%59.9%46.7%
Research & Development28.38M26.81M26.06M31.08M35.92M
Selling, General & Admin92.91M91.85M92.82M104.64M138.85M
Operating Expenses121.29M149.63M118.99M133.74M174.53M
Depreciation & Amortization4.88M5.41M8.29M8.36M18.93M
EBITDA(50.3M)(67.89M)(36.37M)(29.74M)(93.35M)
EBITDA Margin-45.5%-64.3%-30.0%-22.0%-67.3%
Operating Income(56.52M)(104.26M)(45.99M)(52.62M)(109.82M)
Operating Margin-51.1%-98.8%-38.0%-38.8%-79.2%
Interest Income05.13M15.84M14.66M8.57M
Interest Expense403K0000
Other Income / Expenses937K4.85M18.36M14.52M(2.46M)
Income Before Tax(55.58M)(99.41M)(27.64M)(38.1M)(112.27M)
Pre-Tax Margin-50.3%-94.2%-22.8%-28.1%-81.0%
Income Tax Expense(36K)164K719K434K(5.12M)
Net Income(55.55M)(99.57M)(28.35M)(38.53M)(107.15M)
Net Margin-50.2%-94.4%-23.4%-28.4%-77.3%
EPS (Basic)(1.60)(2.61)(0.86)(1.00)(2.51)
EPS (Diluted)(1.60)(2.61)(0.86)(1.00)(2.51)
Weighted Avg Shares36M36.99M37.59M38.37M42.64M
Weighted Avg Shares (Diluted)36M36.99M37.59M38.37M42.64M

Quanterix Corporation

NASDAQ:QTRX

Intrinsic Alpha fair value

Locked

Current Price

$2.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.